20
th IVBM
Helsinki, June 3-7, 2018
Register Today!
Vasculata 2018
St. Louis, MO
July 23 - 26, 2018
Vascular Biology
Newport, RI
October 14-18, 2018
|
Newsletter Archive
Career Center
Job seekers - visit our career center, upload your CV, get email alerts when jobs are posted
Employers - post your job on the job board. NAVBO members get a $150 discount!
http://www.navbo.org/jobs
|
Shop at Amazon?
Help Support NAVBO
|
|
 |
|
|
It's Not Too Late to Register for the IVBM
|
 |
|
|
June 3-7
|
Register Today
As the premier international event in vascular biology, IVBM2018 provides a unique opportunity for the international biomedical community to unite and exchange information, identify new directions, and support the next generation of scientists in vascular medicine. Organized biennially, the IVBM is widely recognized as a showcase for cutting edge basic and translational research in vascular biology.
Register Today!
|
Call for Trainees for NAVBO Committees
If you are interested in being on the Education, Communication or Membership Committee, please send your application to the appropriate committee chair by today, May 31. Go to www.navbo.org/cte-application for more information.
Early bird registrations end:
Vasculata 2018 - June 1
Vascular Biology 2018 - August 15
Abstract submission deadlines:
Vasculata 2018 - June 18
Vascular Biology 2018 - August 1
Nominate a colleague for a Meritorious Award:
Nominations for the 2019 Earl P. Benditt Award and the Judah Folkman Award in Vascular Biology are due July 8.
NAVBO Travel Awards are available for the following meetings:
|
|
NAVBO Travel Award Recipients
|
|
NAVBO's Updated Privacy Policy
|
Your data privacy and security are important to NAVBO. To that end, we have updated our privacy policy to reflect recent privacy and security regulation implementations and changes.
Please review our policy as time permits so you have a complete understanding of the data we have, why we have it, and how we use it.
Part of the updates relate directly to the European Union's new General Data Protection Regulation (GDPR) that went into place May 25. The GDPR seeks to improve the transparency of data usage and give end users more control over their own data. We believe these changes are important and will be compliant with the GDPR regulations.
Contact NAVBO if you have any questions or to
change your communication preferences.
Please note, you can unsubscribe to this newsletter at anytime by clicking on the SafeUnsubscribe in the footer.
|
June 14 Webinar with Juan Melero-Martin
Join us on June 14 at 1:00pm EDT for Dr. Melero-Martin's presentation,
"Engraftment of Bioengineered Vascular Networks." Dr. Melero-Martin is an Associate Professor at Boston Children's Hospital.
To register for the webinar please go to
http://www.navbo.org/events/webinars/711-webinar062018
August 2 Webinar with Michael Dellinger
Our webinar attendees requested a webinar on Lymphatics, so please join us on August 2 at 1:00pm EDT for Dr. Dellinger's presentation,
"Lymphatic Vessels and Vanishing Bones: Animal Models of Lymphatic Anomalies with Bone Involvement." Dr. Dellinger is an Assistant Professor at UT Southwestern Medical Center.
The webinar is sponsored by the Lymphatic Malformation Institute and the Lymphangomatosis & Gorham's Disease Alliance.
To register for the webinar please go to
http://www.navbo.org/events/webinars/718-webinar082018
Please note: we will not be holding a July webinar
|
|
ENIGMA Young Investigator Prize
|
The "Verein für wissenschaftliche Fachtagungen in der Biomedizin" (VWFB) wants to encourage young scientists to develop bold ideas and hypotheses in emerging fields of contemporary life science research and to discuss such ideas with a small and dedicated group of scientists.Therefore, the (VWFB) has announced the 15.000€ ENIGMA Young Investigator Prize (ENIGMA YIP) to enable a junior scientist to host a small, closed and informal think-tank meeting on a topic of his/her choice.
Details of the prize are outlined in this pdf and on VWFB's website (
www.vwfb.de).
The deadline for submission of applications is June 20, 2018.
Please alert your colleagues and your most promising junior scientists of this unique opportunity.
|
|
Spotlight on Trainees
(from the May 3 issue)
|
Applications solicited for Science and SciLifeLab's Prize for Young Scientists
For the sixth year, Science/AAAS and SciLifeLab, a coordinated effort of four universities, have joined forces to recognize outstanding recent doctoral graduates in the life sciences (Ph.D. awarded between January 1, 2016, and December 31, 2017). This award, intended to provide encouragement to young scientists beginning their scientific careers, includes a grand prize of $30,000, as well as $10,000 to winners in each of three other subject categories (Cell and Molecular Biology; Genomics and Proteomics; Ecology and Environment; Translational Medicine). Applications are due July 15, 2018. Winners will have their essays prominently published and will be honored in Stockholm, Sweden, in December of this year.
|
The Lab of Dr. Elisa Boscolo
|
|
Recent Publications by NAVBO Members
|
| Consensus guidelines for the use and interpretation of angiogenesis assays
Angiogenesis
The formation of new blood vessels, or angiogenesis, is a complex process that plays important roles in growth and development, tissue and organ regeneration, as well as numerous pathological conditions. Read more Lack of Tone in Mouse Small Mesenteric Arteries Leads to Outward Remodeling, which can be Prevented by Prolonged Agonist-Induced Vasoconstriction
American Journal of Physiology - Heart and Circulatory Physiology
Inward remodeling of resistance vessels is an independent risk factor for cardiovascular events. Thus far, the remodeling process remains incompletely elucidated, but the activation level of the vascular smooth muscle cell (VSMC) appears to play a central role. Read more |
Industry News (from the May 3 issue)
|
Occurrence of vector-borne diseases jumps over last decade
Researchers at the Centers for Disease Control and Prevention report that the number of
vector-borne illnesses in the U.S. tripled
to nearly 650,000 cases over the period from 2004 to 2016. Cases of tick-borne disease led the way, more than doubling to account for more than three-quarters of all vector-borne disease. Lyme disease represented the vast majority of tick-borne diseases during this interval. The Lyme disease burden is 300,000, a number 10 times higher than what is nationally reported. In rare cases, infection of the heart by the Lyme pathogen Borrelia burgdorferi can cause Lyme carditis, associated with arrhythmias and sudden cardiac death. Warmer weather is coming - check for ticks after time outdoors!
Single-cell RNA sequencing in breast cancer-associated endothelial cells
Oncotarget
Investigators at UC-San Francisco, UC-Irvine and National Cheng Kung University in Taiwan have characterized global gene expression profiles of tumor-associated endothelial cells isolated from human breast cancerous tissues compared with those in normal breast tissue, using single cell RNA sequencing. More than 1300 genes were differentially expressed between these two EC phenotypes. Bioinformatic analysis separated the cancerous versus control ECs into two distinctive clusters, and disease biomarker analysis indicated that these differentially expressed genes are highly correlated with breast neoplasm diseases. Enrichment analysis software associated these genes with extracellular matrix signaling pathways. The authors conclude that ECM-associated genes play pivotal roles in breast cancer EC biology, some potentially serving as tumor-associated endothelial cell biomarkers for distinct cancers.
Hippo Signaling in Cardiac Fibroblast Development
Developmental Cell
During development, the cardiac epicardium contains progenitors of non-cardiomyocytes that are essential for eventual cardiac function. Hippo, a kinase-dependent pathway that inhibits Yap-mediated transcription, is a regulator of organ size in developing hearts. Epicardial-specific deletion of the Hippo kinases Lats1/2 was lethal in embryos, associated with defective coronary vasculature remodeling. Lats1/2 mutant cells were arrested in their developmental trajectory, with epicardial markers persisting and expanded expression of Yap transcriptional targets.
|
|
Job Postings
|
|
Job Title
|
Company
|
Location
|
|
|
Tufts Medical Center
|
Boston, MA
|
Postdoc position in Signal Transduction, Cardiovascular and Cell Biology
|
BloodCenter of Wisconsin
|
Milwaukee, WI
|
|
|
Brigham and Women's Hospital, Harvard Medical Shool
|
Boston, MA
|
Postdoctoral Fellow
|
Yale University School of Medicine
|
New Haven, CT
|
|
|
Cleveland Clinic
|
Cleveland, OH
|
Postdoctoral fellow
|
University of Washington
|
Seattle, WA
|
|
|
UMass Medical School
|
Worcester, MA
|
Research Associate in Redox Signaling
|
LSU Health Sciences Center - Shreveport
|
Shreveport, LA
|
|
|
|
